Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)

Historic Tax Provisions for Ovid Therapeutics (OVID) over the last 2 years, with Q1 2022 value amounting to $50000.0.

  • Ovid Therapeutics' Tax Provisions fell 9000.55% to $50000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $50000.0, marking a year-over-year decrease of 9623.73%. This contributed to the annual value of $1.3 million for FY2021, which is N/A changed from last year.
  • Ovid Therapeutics' Tax Provisions amounted to $50000.0 in Q1 2022, which was down 9000.55% from -$349714.0 recorded in Q4 2021.
  • In the past 5 years, Ovid Therapeutics' Tax Provisions ranged from a high of $1.5 million in Q2 2021 and a low of -$349714.0 during Q4 2021